Process for making fluorinated 4-azasteroid derivatives
View Patent ↗The present invention relates to synthetic processes useful in the preparation of fluorinated 4-azasteroid derivatives that modulate androgen receptors and have application in the treatment of conditions caused by androgen deficiency or androgen receptor hyperactivity, such as osteoporosis, periodontal disease, bone fracture, frailty, erectile dysfunction, loss of libido, androgen-dependent cancers and sarcopenia. The present invention also encompasses intermediates useful in the disclosed synthetic processes and the methods of their preparation.
1. A process for preparing an aza-steroid amide of Formula X
which comprises:
(1) iodinating compound XI to afford a 2-iodo compound XII;
(2) displacing the iodine in compound XII with fluorine to afford a 2-fluoro compound XIII;
(3) methylating the lactam nitrogen of compound XIII to afford compound XIV;
(4) oxidizing compound XIV to afford compound XV;
(5) hydrolyzing ester XV to afford acid XVI; and
(6) coupling of acid XVI with amine XVII to afford aza-steroid amide X.
2. The process according to claim 1 , wherein the iodination in (1) comprises the reaction of trimethylsilyichionde and I 2 ; the displacement in (2) comprises the reaction of silver (I) fluoride in N,N-dimethylacetamide, dichioromethane, dichioromethane/acetonitrile, or acetonitrile; the methylation of (3) comprises the reaction of t-BuOK and MeI; the oxidation of (4) comprises the reaction of lithiumhexamethyldisilazide and methylbenzenesulfinate; the hydrolysis in (5) comprises the reaction of NaOH or KOH; and the coupling in (6) comprises the reaction of 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride or 1,1′-carbonyldiimidazole.
3. The process according to claim 1 , wherein the iodination in (1) comprises the reaction of trimethylsilylchloride and I 2 to form a 2-iodo lactam product; the displacement in (2) comprises the conversion of the 2-iodo lactam product formed in step (1) by treatment with N,N-dimethyl formamide (DMF) and water, followed by treatment with Deoxo-Fluor®; the methylation of (3) comprises the reaction of t-BuOK and MeI; the oxidation of (4) comprises the reaction of lithiumhexamethyldisilazide and methylbenzenesulfinate; the hydrolysis in (5) comprises the reaction of NaOH or KOH; and the coupling in (6) comprises the reaction of 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride or 1,1′-carbonyldiimidazole.